New and improved cultivars for the worldwide orchid market are vital, and in everyones interest.

As a Research and Development company our goal is to constantly improve the Oncidiinae cultivars available to commercial orchid growers. We will then enter into a License agreement with interested growers to produce our plants with authorized stock. We do this to ensure the quality of the mericlone program that those growers enter into, stable and virus free material is to everyones benefit.

This License Agreement will define how many plants the grower will produce, the period of time in which they will produce them, where the plants may be marketed, and what will be the cost per plant to be paid as a license fee. It is through agreements like this that production stability and profitability is best assured. It is also the only way that a business that relies on producing new cultivars, such as Mauna Kea Orchids, can survive as a self-sustaining entity.

Our License Fee will range between U.S. .05 -.25 cents per plant.